Analytical Method Development And Validation For Determination Of Nitrosamine Impurities N-Nitrosodibutylamine (Ndba) & Nitroso Of N-Dimethyl Erythromycin In Sertraline Hcl Drug Substance By Lc-Ms/Ms

This work provides a thorough assessment of a method for measuring N-nitrosodibutylamine and N-nitroso of N-dimethyl erythromycin A, two substances with substantial regulatory interest because of their health hazards. The performance characteristics of the method were thoroughly investigated through a series of experiments, including standard solution analysis, quantitation and detection limit determination, linearity assessment, precision testing at various levels, and accuracy evaluation via recovery studies. The findings demonstrate that the technique performs exceptionally well in terms of linearity, accuracy, and precision over a broad range of concentrations. The results indicate that the suggested approach has the potential to accurately quantify these chemicals in a range of sample matrices, making it a useful tool for regulatory compliance and quality assurance in associated industries.

Authors

Publication Details

Journal
Nanotechnology Perceptions
Published
2024-11-04
DOI
https://doi.org/10.62441/nano-ntp.vi.2776
Primary Topic
Pharmacological Effects and Assays
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Analytical Method Development And Validation For Determination Of Nitrosamine Impurities N-Nitrosodibutylamine (Ndba) & Nitroso Of N-Dimethyl Erythromycin In Sertraline Hcl Drug Substance By Lc-Ms/Ms

Sanjeev Giri, U. K. Misra
Nanotechnology Perceptions
Pharmacological Effects and Assays
article

Analytical Method Development And Validation For Determination Of Nitrosamine Impurities N-Nitrosodibutylamine (Ndba) & Nitroso Of N-Dimethyl Erythromycin In Sertraline Hcl Drug Substance By Lc-Ms/Ms

Sanjeev Giri, U. K. Misra
article en

Abstract

This work provides a thorough assessment of a method for measuring N-nitrosodibutylamine and N-nitroso of N-dimethyl erythromycin A, two substances with substantial regulatory interest because of their health hazards. The performance characteristics of the method were thoroughly investigated through a series of experiments, including standard solution analysis, quantitation and detection limit determination, linearity assessment, precision testing at various levels, and accuracy evaluation via recovery studies. The findings demonstrate that the technique performs exceptionally well in terms of linearity, accuracy, and precision over a broad range of concentrations. The results indicate that the suggested approach has the potential to accurately quantify these chemicals in a range of sample matrices, making it a useful tool for regulatory compliance and quality assurance in associated industries.

Nanotechnology Perceptions
Industry, innovation and infrastructure
Openalex Percentile: Top 74%
Pharmacological Effects and Assays
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Analytical Method Development And Validation For Determination Of Nitrosamine Impurities N-Nitrosodibutylamine (Ndba) & Nitroso Of N-Dimethyl Erythromycin In Sertraline Hcl Drug Substance By Lc-Ms/Ms — Sanjeev Giri, U. K. Misra · Nanotechnology Perceptions (2024) | TGRS Research Map | TGRS